查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771458

过敏诊断市场规模、份额、趋势分析报告：按产品/服务、过敏原、测试类型、最终用途、地区、细分市场预测，2025-2030 年

Allergy Diagnostics Market Size, Share & Trends Analysis Report By Products And Services, By Allergen, By Test Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10个工作天内

价格

过敏诊断市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球过敏诊断市场规模预计到2030年将达到116.3亿美元，2025-2030年期间的复合年增长率为10.39%。

过敏仍然是美国乃至全球的重大公共卫生问题，影响着儿童和成人。根据美国疾病管制与预防中心 (CDC) 2023 年的全国健康访问调查 (NHIS)，约有 25.7% 的美国成人和 18.9% 的儿童报告被诊断患有季节性过敏、湿疹或食物过敏。这些数据凸显了过敏性疾病盛行率的不断上升，反映出迫切需要更好的诊断工具和早期检测策略，以减少併发症并提高生活品质。

此外，根据过敏和气喘网路的统计，每年有超过5000万美国患有过敏症，过敏是美国第六大慢性病原因。光是食物过敏就影响了大约560万儿童（约每13人中就有1人）和大约2600万成年人，这进一步凸显了对准确和易于获取的诊断解决方案的需求。此外，通常由过敏原引发的气喘影响超过2500万美国，其中包括420万名儿童。这些数字显示过敏性疾病的医疗负担日益加重，并支持对先进诊断和早期疗育进行投资的必要性。

美国人口结构变化

  • 成人：
    • 与非西班牙裔黑人（24%）、西班牙裔（18.8%）和非西班牙裔亚裔（17%）成年人相比，非西班牙裔白人成年人更容易患有季节性过敏症（28.4%）。
    • 女性湿疹的盛行率（8.9%）高于男性（5.7%）。
    • 非西班牙裔黑人成年人的食物过敏盛行率（8.5%）高于西班牙裔（4.4%）、非西班牙裔白人（6.2%）和非西班牙裔亚裔（4.5%）成年人。
  • 孩子：
    • 男孩（20%）比女孩（17.7%）更容易有季节性过敏。
    • 6～11岁儿童湿疹盛行率最高（12.1%），其次为0～5岁儿童（10.4%）及12～17岁儿童（9.8%）。
    • 与西班牙裔儿童（5%）和非西班牙裔白人儿童（5.3%）相比，非西班牙裔黑人儿童更容易出现食物过敏（7.6%）。

过敏性疾病的经济影响也十分显着，每年因急诊、住院和生产力损失，美国医疗保健系统损失数十亿美元。不断上升的过敏盛行率、医疗成本以及严重过敏反应的风险，共同催生了市场对创新过敏诊断试剂盒的迫切需求，这些试剂盒应具备准确性、快速性和可及性，适用于从基层医疗到专科诊所，甚至家用检测套组等各种环境。

全球过敏诊断市场的主要企业包括赛默飞世尔科技公司、HYCOR Biomedical、EUROIMMUN Medizinische Labordiagnostika AG（PerkinElmer，Inc.）、Omega Diagnostics Group PLC、Lincoln Diagnostics，Inc.、AESKU.GROUP GmbH、Minabharm Group.R. AG、bioMerieux 和西门子医疗股份有限公司。

这些公司积极参与策略性倡议，例如新产品发布、监管核准和技术进步，以加强其在全球市场的地位并扩展其过敏检测产品组合。例如，赛默飞世尔科技于2022年5月推出了高通量体外过敏和自体免疫检测的Phadia 2500+系列，以扩展其在美国的过敏诊断产品组合，并提高实验室效率和精准诊断。此次产品发布满足了对全面过敏检测组和分子水平检测日益增长的需求，以应对美国和欧洲等主要市场日益增多的食物过敏和呼吸道过敏病例，尤其是在老年人和儿童群体中。

过敏诊断市场报告重点

  • 根据产品和服务，耗材在 2024 年占据了最大的收入份额，为 63.14%。这种主导地位归因于需要频繁补充试剂、检测套组和其他对过敏测试程序至关重要的消耗品，以及全球过敏诊断测试数量的不断增加。
  • 按过敏原划分，吸入式过敏将占据市场主导地位，到 2024 年将占据 49.72% 的最大收益占有率。这主要是由于花粉、尘螨、霉菌孢子、动物皮屑等空气传播的过敏原引起的呼吸道过敏盛行率很高，需要进行广泛和常规的诊断测试。
  • 根据测试类型，试管内测试在 2024 年占据市场最高收益占有率。试管内测试之所以受到青睐，是因为它们安全性高、可重复性强，并且能够提供可同时检测多种过敏原的综合面板，这使得它们在临床和研究环境中都受到青睐。
  • 根据最终用途，医院和诊所将在 2024 年占据最高的收入份额，达到 37.23%，这是由于过敏诊断越来越多地融入医院的门诊护理、转诊至专科过敏护理的数量不断增加以及从临床角度对准确的实验室测试的需求。
  • 从地区来看，北美将引领全球市场，占 2024 年营收的 36.53%。这种主导地位可以归因于该地区完善的医疗保健基础设施、对过敏相关健康风险的高度认识、强有力的报销政策以及提供先进诊断解决方案的主要行业参与者的存在。
  • 预计亚太地区将成长最快，2024 年至 2030 年的复合年增长率为 11.43%。推动这一成长的因素包括都市化加快、环境污染加剧、饮食习惯改变导致新的食物过敏以及医疗保健服务的普及，尤其是在中国和印度等新兴经济体。

目录

第一章调查方法与范围

第二章执行摘要

3. 过敏诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 过敏诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章过敏诊断市场：产品和服务估计和趋势分析

  • 2024 年和 2030 年按产品和服务分類的市场占有率
  • 细分仪表板
  • 全球过敏诊断市场（按产品/服务）展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 装置
    • 耗材
    • 服务

第五章过敏诊断市场：过敏原估计与趋势分析

  • 2024 年及 2030 年过敏原市场占有率
  • 细分仪表板
  • 全球过敏诊断市场（按过敏原）
  • 2018年至2030年市场规模、预测及趋势分析
    • 食物
    • 吸入
    • 其他的

第六章过敏诊断市场：测试类型估计和趋势分析

  • 2024 年和 2030 年各测试类型的市场占有率
  • 细分仪表板
  • 全球过敏诊断市场展望（按测试类型）
  • 2018年至2030年市场规模、预测及趋势分析
    • 体内测试

第七章过敏诊断市场：最终用途估计与趋势分析

  • 2024 年和 2030 年按最终用途分類的市场占有率
  • 细分仪表板
  • 全球过敏诊断市场展望（按最终用途）
  • 2018年至2030年市场规模、预测及趋势分析
    • 研究所
    • 医院和诊所
    • 诊断实验室
    • 其他的

第八章过敏诊断市场：区域估计和趋势分析

  • 2024 年及 2030 年各地区市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
    • 北美：SWOT分析
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲：SWOT分析
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太地区：SWOT分析
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 拉丁美洲：SWOT分析
    • 巴西
    • 阿根廷
  • 中东和非洲
    • MEA：SWOT分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Key company market share analysis, 2024
    • Thermo Fisher Scientific, Inc.
    • HYCOR Biomedical
    • EUROIMMUN Medizinische Labordiagnostika AG（PerkinElmer, Inc.）
    • Omega Diagnostics Group PLC
    • Lincoln Diagnostics, Inc.
    • AESKU.GROUP GmbH
    • Minaris Medical America, Inc.
    • HOB Biotech Group Corp., Ltd.
    • DASIT Group SPA
    • R-Biopharm AG
    • bioMerieux
    • Siemens Healthcare GmbH
Product Code: GVR-4-68040-600-0

Allergy Diagnostics Market Growth & Trends:

The global allergy diagnostics market size is expected to reach USD 11.63 billion by 2030, registering a CAGR of 10.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. Allergies continue to be a significant public health concern in the U.S. and worldwide, affecting both children and adults across all demographics. According to the CDC's 2023 National Health Interview Survey (NHIS), approximately 25.7% of adults and 18.9% of children in the U.S. reported being diagnosed with seasonal allergies, eczema, or food allergies. This data highlights the growing prevalence of allergic conditions, reflecting an urgent need for better diagnostic tools and early detection strategies to reduce complications and improve quality of life.

Additionally, statistics from the Allergy & Asthma Network reveal that over 50 million Americans suffer from allergies each year, making them the sixth leading cause of chronic illness in the U.S. Food allergies alone affect an estimated 5.6 million children (around one in 13), and about 26 million adults further underlining the need for precise and accessible diagnostic solutions. Moreover, asthma, which is often triggered by allergens, affects more than 25 million Americans, including 4.2 million children. These figures point to the growing healthcare burden of allergic diseases and support the case for investments in advanced diagnostics and early intervention.

U.S. Demographic Variations:

  • Adults:
    • Non-Hispanic White adults were more likely to have seasonal allergies (28.4%) compared to Non-Hispanic Black (24%), Hispanic (18.8%), and Non-Hispanic Asian (17%) adults.
    • Eczema prevalence was higher among women (8.9%) than men (5.7%).
    • Non-Hispanic Black adults had a higher prevalence of food allergies (8.5%) compared to Hispanic (4.4%), Non-Hispanic White (6.2%), and Non-Hispanic Asian (4.5%) adults.
  • Children:
    • Boys (20%) were more likely to have seasonal allergies than girls (17.7%).
    • Children aged 6-11 years had the highest prevalence of eczema (12.1%), followed by those aged 0-5 years (10.4%), and 12-17 years (9.8%).
    • Non-Hispanic Black children were more likely to have food allergies (7.6%) compared to Hispanic (5%) and Non-Hispanic White (5.3%) children

The economic impact of allergic diseases is also substantial, costing the U.S. healthcare system billions annually due to emergency visits, hospitalizations, and lost productivity. The combination of rising prevalence, healthcare costs, and the risk of severe allergic reactions has created a compelling market demand for innovative allergy diagnostics that can offer accuracy, speed, and accessibility across various settings, from primary care to specialty clinics and even at-home testing kits.

Some of the key players in the global allergy diagnostics market include Thermo Fisher Scientific, Inc., HYCOR Biomedical, EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.), Omega Diagnostics Group PLC, Lincoln Diagnostics, Inc., AESKU.GROUP GmbH, Minaris Medical America, Inc., HOB Biotech Group Corp., Ltd., DASIT Group SPA, R-Biopharm AG, bioMerieux, and Siemens Healthcare GmbH.

These companies are actively engaged in strategic initiatives such as new product launches, regulatory approvals, and technology advancements to strengthen their global market presence and expand their allergy testing portfolios. For instance, in May 2022, Thermo Fisher Scientific expanded its allergy diagnostics offering in the U.S. by launching its Phadia 2500+ series for high-throughput in vitro allergy and autoimmune testing, enhancing lab efficiency and precision diagnostics. This launch supports the growing demand for comprehensive allergy panels and molecular-level testing, addressing increasing cases of food and respiratory allergies, particularly in aging and pediatric populations across key markets like the U.S. and Europe.

Allergy Diagnostics Market Report Highlights:

  • Based on products and services, consumables accounted for the largest revenue share of 63.14% in 2024. This dominance is attributed to the frequent need for replenishment of reagents, test kits, and other consumable materials essential for allergy testing procedures, as well as the increasing volume of allergy diagnostic tests conducted globally.
  • Based on allergen, inhaled dominated the market and accounted for the largest revenue share of 49.72% in 2024. This is primarily due to the high prevalence of respiratory allergies caused by airborne allergens such as pollen, dust mites, mold spores, and animal dander, which necessitate widespread and routine diagnostic testing.
  • Based on test type, the in vitro test led the market with the highest revenue share in 2024. The preference for in vitro tests is driven by their safety, reproducibility, and ability to provide comprehensive panels that can detect multiple allergens simultaneously, making them a preferred choice in both clinical and research settings.
  • Based on end use, hospitals and clinics held the highest revenue share of 37.23% in 2024. This is due to the growing integration of allergy diagnostics into hospital outpatient services, increasing referrals for specialized allergy care, and the demand for accurate, laboratory-based testing within clinical settings.
  • Based on region, North America led the global market, accounting for 36.53% of the revenue in 2024. This dominance is attributed to the region's well-established healthcare infrastructure, high awareness of allergy-related health risks, strong reimbursement policies, and the presence of key industry players offering advanced diagnostic solutions.
  • The Asia Pacific region is projected to witness the fastest growth, with a CAGR of 11.43% from 2024 to 2030. Factors driving this growth include rising urbanization, increasing environmental pollution, changing dietary habits leading to new food allergies, and expanding access to healthcare services, particularly in emerging economies such as China and India.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Products and Services
    • 1.2.2. Allergen
    • 1.2.3. Test Type
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Products and Services Outlook
    • 2.2.2. Test Type Outlook
    • 2.2.3. Allergen Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Allergy Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing Allergy Prevalence
      • 3.2.1.2. Advancements in Diagnostic Techniques
      • 3.2.1.3. Significant investments from government bodies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited accessibility to advanced technologies
      • 3.2.2.2. High Manufacturing Costs
  • 3.3. Allergy Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Allergy Diagnostics Market: Products and Services Estimates & Trend Analysis

  • 4.1. Products and Services Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Allergy Diagnostics Market by Products and Services Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Instruments
      • 4.4.1.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Consumables
      • 4.4.2.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Services
      • 4.4.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Allergy Diagnostics Market: Allergen Estimates & Trend Analysis

  • 5.1. Allergen Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Allergy Diagnostics Market by Allergen Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Food
      • 5.4.1.1. Food market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.2. Dairy Products
        • 5.4.1.2.1. Dairy products market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.3. Poultry Product
        • 5.4.1.3.1. Poultry products market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.4. Tree Nuts
        • 5.4.1.4.1. Tree nuts market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.5. Peanuts
        • 5.4.1.5.1. Peanuts market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.6. Shellfish
        • 5.4.1.6.1. Shellfish market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.7. Wheat
        • 5.4.1.7.1. Wheat market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.8. Soys
        • 5.4.1.8.1. Soys market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.9. Other Food Allergens
        • 5.4.1.9.1. Other food allergens market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Inhaled
      • 5.4.2.1. Inhaled market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Other Allergens
      • 5.4.3.1. Other Allergens market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Allergy Diagnostics Market: Test Type Estimates & Trend Analysis

  • 6.1. Test Type Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Allergy Diagnostics Market by Test Type Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. In Vivo Test
      • 6.4.1.1. In Vivo Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.2. Skin Prick Test
        • 6.4.1.2.1. Skin Prick Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.3. Intradermal Test
        • 6.4.1.3.1. Intradermal Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.4. Patch Test
        • 6.4.1.4.1. Patch Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.5. In vitro Test
      • 6.4.1.6. In Vitro market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Allergy Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Allergy Diagnostics Market by End Use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Research Institutions
      • 7.4.1.1. Research Institutions market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Hospitals & Clinics
      • 7.4.2.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Diagnostic Laboratories
      • 7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Allergy Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts, Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. North America: SWOT Analysis
    • 8.5.2. U.S.
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. Europe: SWOT Analysis
    • 8.6.2. UK
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. Germany
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. France
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Italy
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Spain
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Norway
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Sweden
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.9. Denmark
      • 8.6.9.1. Key country dynamics
      • 8.6.9.2. Regulatory framework
      • 8.6.9.3. Competitive scenario
      • 8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific: SWOT Analysis
    • 8.7.2. Japan
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. China
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. India
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. Australia
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. South Korea
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.7. Thailand
      • 8.7.7.1. Key country dynamics
      • 8.7.7.2. Regulatory framework
      • 8.7.7.3. Competitive scenario
      • 8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Latin America: SWOT Analysis
    • 8.8.2. Brazil
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. MEA: SWOT Analysis
    • 8.9.2. South Africa
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Key country dynamics
      • 8.9.5.2. Regulatory framework
      • 8.9.5.3. Competitive scenario
      • 8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Thermo Fisher Scientific, Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Services benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. HYCOR Biomedical
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Services benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Services benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Omega Diagnostics Group PLC
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Services benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Lincoln Diagnostics, Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Services benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. AESKU.GROUP GmbH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Services benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Minaris Medical America, Inc.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Services benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. HOB Biotech Group Corp., Ltd.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Services benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. DASIT Group SPA
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Services benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. R-Biopharm AG
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Services benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. bioMerieux
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Services benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. Siemens Healthcare GmbH
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Services benchmarking
      • 9.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 List of Secondary Sources
  • Table 3 Regulatory Framework
  • Table 4 Global Allergy Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 6 Global Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 7 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 8 Global Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 9 North America Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 11 North America Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 12 North America Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 North America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 14 North America Allergy Diagnostics Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 U.S. Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 16 U.S. Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 17 U.S Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 U.S. Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 19 Canada Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 20 Canada Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 21 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 Canada Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 23 Mexico Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 24 Mexico Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 25 Mexico Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 Mexico Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 27 Europe Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 28 Europe Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 29 Europe Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 30 Europe Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 31 Europe Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 32 UK Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 33 UK Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 34 UK Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 UK Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 36 Germany Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 37 Germany Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 38 Germany Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 39 Germany America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 40 France Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 41 France Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 42 France Rapid Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 43 France Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 44 Spain Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 45 Spain Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 46 Spain Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 48 Italy Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 49 Italy Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 50 Italy Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 51 Italy Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 56 Asia-Pacific Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 57 China Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 58 China Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 59 China Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 60 China Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 61 Japan Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 62 Japan Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 63 Japan Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 65 India Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 66 India Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 67 India Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 68 India Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 69 South Korea Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 70 South Korea Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 71 South Korea Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 72 South Korea Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 73 Australia Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 74 Australia Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 75 Australia Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 76 Australia Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 77 Latin America Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 78 Latin America Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 79 Latin America Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 80 Latin America Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 81 Latin America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 82 Brazil Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 83 Brazil Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 84 Brazil Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 85 Brazil Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 86 Argentina Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 87 Argentina Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 88 Argentina Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 89 Argentina Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 90 MEA Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 91 MEA Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 92 MEA Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 93 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 94 MEA Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 95 South Africa Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 96 South Africa Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 97 South Africa Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 98 South Africa Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 99 UAE Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 100 UAE Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 101 UAE Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 102 UAE Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 107 Kuwait Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 108 Kuwait Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 109 Kuwait Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 110 Kuwait Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Allergy Diagnostics: market outlook
  • Fig. 14 Allergy Diagnostics competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Allergy Diagnostics driver impact
  • Fig. 20 Allergy Diagnostics restraint impact
  • Fig. 21 Allergy Diagnostics strategic initiatives analysis
  • Fig. 22 Allergy Diagnostics: Products and Services movement analysis
  • Fig. 23 Allergy Diagnostics: Products and Services outlook and key takeaways
  • Fig. 24 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Allergy Diagnostics: Allergen movement analysis
  • Fig. 28 Allergy Diagnostics: Allergen outlook and key takeaways
  • Fig. 29 Food market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Dairy Products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Poultry Product market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Tree Nuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Peanuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Shellfish market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Wheat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Soys market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other Food Allergens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Inhaled market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other Allergens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Allergy Diagnostics: Test Type movement analysis
  • Fig. 41 Allergy Diagnostics: Test Type outlook and key takeaways
  • Fig. 42 In Vivo Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Skin Prick Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Intradermal Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Patch Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 In Vitro market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Allergy Diagnostics: End use movement analysis
  • Fig. 49 Allergy Diagnostics: End use outlook and key takeaways
  • Fig. 50 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Diagnostics Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Research Institutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Global allergy diagnostics market: Regional movement analysis
  • Fig. 55 Global allergy diagnostics market: Regional outlook and key takeaways
  • Fig. 56 Global allergy diagnostics market shares and leading players
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico
  • Fig. 64 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Europe
  • Fig. 66 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 UK
  • Fig. 68 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Germany
  • Fig. 70 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 France
  • Fig. 72 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Italy
  • Fig. 74 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Spain
  • Fig. 76 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Denmark
  • Fig. 78 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Sweden
  • Fig. 80 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Norway
  • Fig. 82 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Asia Pacific
  • Fig. 84 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 China
  • Fig. 86 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Japan
  • Fig. 88 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 India
  • Fig. 90 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand
  • Fig. 92 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 South Korea
  • Fig. 94 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Australia
  • Fig. 96 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America
  • Fig. 98 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil
  • Fig. 100 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 South Africa
  • Fig. 106 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Saudi Arabia
  • Fig. 108 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Market share of key market players - Allergy Diagnostics